| Aktier | 585,248 Mrd. | — | KO KoAct | 0 | Sundhedsvæsen | | 3.8.2023 | 21.596,8 | 8,05 | 37,04 |
KO | Aktier | 286,374 Mrd. | — | KO KODEX | 0,45 | Sundhedsvæsen | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 11.865,53 | 5,44 | 37,93 |
TE | Aktier | 265,194 Mrd. | — | TE Tiger ETF | 0,4 | Sundhedsvæsen | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8.021,07 | 6,03 | 51,44 |
TE | Aktier | 189,277 Mrd. | — | TE Tiger ETF | 0,4 | Sundhedsvæsen | KRX Healthcare - KRW | 15.7.2011 | 46.695,71 | 4,63 | 39,62 |
TE | Aktier | 97,468 Mrd. | — | TE Tiger ETF | 0,3 | Sundhedsvæsen | NASDAQ / Biotechnology | 26.8.2014 | 31.635,63 | 4,88 | 21,01 |
KO | Aktier | 94,881 Mrd. | — | KO KODEX | 0,09 | Sundhedsvæsen | KRX Healthcare - KRW | 28.3.2017 | 21.243,97 | 4,63 | 39,65 |
TE | Aktier | 74,278 Mrd. | — | TE Tiger ETF | 0,4 | Sundhedsvæsen | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 18.235,61 | 10,44 | 59,1 |
| Aktier | 71,702 Mrd. | — | KR KB RISE | 0 | Sundhedsvæsen | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 15.679,68 | 9,56 | 68,04 |
TE | Aktier | 64,212 Mrd. | — | TE Tiger ETF | 0,49 | Sundhedsvæsen | Solactive China Biotech Index | 3.12.2020 | 8.968,25 | 4,03 | 28,69 |
KO | Aktier | 61,401 Mrd. | — | KO KODEX | 0,25 | Sundhedsvæsen | S&P Health Care Select Sector | 21.3.2023 | 13.619,17 | 4,86 | 22,5 |
TE | Aktier | 44,498 Mrd. | — | TE Tiger ETF | 0,45 | Sundhedsvæsen | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10.059,99 | 7,96 | 17,83 |
KO | Aktier | 42,664 Mrd. | — | KO KODEX | 0,45 | Sundhedsvæsen | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10.794,98 | 5,08 | 12,43 |
SP | Aktier | 38,413 Mrd. | 15,229 Mio. | SP SPDR | 0,08 | Sundhedsvæsen | S&P Health Care Select Sector | 16.12.1998 | 143,29 | 4,86 | 22,63 |
TE | Aktier | 31,309 Mrd. | — | TE Tiger ETF | 0 | Sundhedsvæsen | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 25.608,61 | 0 | 0 |
TE | Aktier | 31,058 Mrd. | — | TE Tiger ETF | 0,4 | Sundhedsvæsen | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 20.822,89 | 2,91 | 30,55 |
| Aktier | 28,453 Mrd. | — | HW Hwabao | 0,6 | Sundhedsvæsen | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aktier | 21,423 Mrd. | — | KO KODEX | 0,25 | Sundhedsvæsen | S&P Biotechnology Select Industry | 31.10.2013 | 41.813,56 | 0 | 0 |
EF | Aktier | 17,417 Mrd. | — | EF E Fund | 0 | Sundhedsvæsen | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,4 | 26,67 |
VA | Aktier | 16,498 Mrd. | 231.887,9 | VA Vanguard | 0,09 | Sundhedsvæsen | MSCI US IMI 25/50 Health Care | 26.1.2004 | 272,55 | 5,01 | 23,09 |
NH | Aktier | 15,996 Mrd. | — | NH NH-Amundi | 0 | Sundhedsvæsen | | 26.11.2024 | 14.892,57 | 5 | 44,18 |
| Aktier | 14,213 Mrd. | — | KO KoAct | 0,5 | Sundhedsvæsen | | 11.11.2025 | 10.338,06 | 5,59 | 22,65 |
| Aktier | 12,596 Mrd. | — | KR KB RISE | 0 | Sundhedsvæsen | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 16.773,64 | 4,73 | 37,18 |
| Aktier | 9,163 Mrd. | — | AC ACE | 0,3 | Sundhedsvæsen | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12.860,55 | 7,21 | 21,79 |
KI | Aktier | 8,411 Mrd. | — | KI Kiwoom | 0,49 | Sundhedsvæsen | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 12.779,55 | 0 | 0 |
IS | Aktier | 8,227 Mrd. | 1,762 Mio. | IS iShares | 0,44 | Sundhedsvæsen | NYSE Biotechnology (TR) | 5.2.2001 | 169,45 | 5,1 | 21,9 |
| Aktier | 8,18 Mrd. | — | AC ACE | 0,45 | Sundhedsvæsen | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12.381,65 | 3,6 | 21,75 |
| Aktier | 7,941 Mrd. | — | KO KoAct | 0 | Sundhedsvæsen | | 27.1.2026 | 10.133,67 | 4,34 | 29,64 |
SP | Aktier | 7,494 Mrd. | 9,357 Mio. | SP SPDR | 0,35 | Sundhedsvæsen | S&P Biotechnology Select Industry | 31.1.2006 | 119,59 | 5,08 | 0 |
| Aktier | 6,848 Mrd. | — | KO KoAct | 0,5 | Sundhedsvæsen | | 3.9.2024 | 12.841,88 | 4,21 | 17,95 |
BO | Aktier | 6,662 Mrd. | — | BO Bosera | 0,65 | Sundhedsvæsen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,61 | 2,75 | 12,8 |
CH | Aktier | 6,371 Mrd. | — | CH ChinaAMC | 0,65 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,82 | 3 | 21,32 |
TE | Aktier | 6,279 Mrd. | — | TE Tiger ETF | 0,5 | Sundhedsvæsen | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 17.612,46 | 2,77 | 23,45 |
KI | Aktier | 5,925 Mrd. | — | KI Kiwoom | 0,49 | Sundhedsvæsen | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11.652,44 | 4,37 | 17,87 |
| Aktier | 5,693 Mrd. | — | MA Maxwealth | 0,6 | Sundhedsvæsen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,49 | 2,64 | 31,06 |
| Aktier | 5,441 Mrd. | — | NI Nippon | 0,19 | Sundhedsvæsen | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aktier | 5,437 Mrd. | — | NF NEXT FUNDS | 0,32 | Sundhedsvæsen | | 21.3.2008 | 33.088,93 | 1,86 | 21,64 |
| Aktier | 5,154 Mrd. | — | KR KB RISE | 0,35 | Sundhedsvæsen | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9.602,93 | 7,72 | 19,09 |
TE | Aktier | 4,915 Mrd. | — | TE Tiger ETF | 0,4 | Sundhedsvæsen | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12.065 | 0 | 0 |
IN | Aktier | 4,859 Mrd. | — | IN Invesco | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,69 | 3,45 | 24,62 |
IC | Aktier | 4,738 Mrd. | — | IC ICBC | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,24 | 0 | 0 |
EF | Aktier | 4,018 Mrd. | — | EF E Fund | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0 | 0 |
GU | Aktier | 3,732 Mrd. | — | GU Guotai | 0,6 | Sundhedsvæsen | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 1 | 0 | 0 |
IS | Aktier | 3,642 Mrd. | 227.363,2 | IS iShares | 0,4 | Sundhedsvæsen | S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net | 13.11.2001 | 93,91 | 4,19 | 21,81 |
XT | Aktier | 3,236 Mrd. | — | XT Xtrackers | 0,25 | Sundhedsvæsen | MSCI World Index / Health Care -SEC | 22.11.2010 | 55,43 | 4,44 | 21,81 |
IS | Aktier | 3,221 Mrd. | 2,437 Mio. | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Medical Equipment | 1.5.2006 | 53,23 | 3,79 | 29,41 |
FU | Aktier | 3,148 Mrd. | — | FU Fullgoal | 0,6 | Sundhedsvæsen | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,44 | 0 | 0 |
IS | Aktier | 2,906 Mrd. | 903.150,2 | IS iShares | 0,38 | Sundhedsvæsen | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 61,66 | 4,86 | 22,76 |
FI | Aktier | 2,823 Mrd. | 189.727,8 | FI Fidelity | 0,08 | Sundhedsvæsen | MSCI US IMI 25/50 Health Care | 21.10.2013 | 70,53 | 4,77 | 22,64 |
NH | Aktier | 2,735 Mrd. | — | NH NH-Amundi | 0,45 | Sundhedsvæsen | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9.115,65 | 3,43 | 26,31 |
IS | Aktier | 2,548 Mrd. | — | IS iShares | 0,15 | Sundhedsvæsen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 11,8 | 4,86 | 22,63 |
| Aktier | 2,455 Mrd. | — | HW Hwabao | 0 | Sundhedsvæsen | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,49 Mrd. | 0 | 0 |
GU | Aktier | 2,304 Mrd. | — | GU Guotai | 0,6 | Sundhedsvæsen | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,9 |
FT | Aktier | 2,289 Mrd. | 62.733,24 | FT First Trust | 0,54 | Sundhedsvæsen | NYSE Arca Biotechnology Index | 19.6.2006 | 202,01 | 3,45 | 22,71 |
CH | Aktier | 2,209 Mrd. | — | CH ChinaAMC | 0,75 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
CH | Aktier | 2,209 Mrd. | — | CH ChinaAMC | 0,75 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 15,76 | 3,09 | 22,35 |
PA | Aktier | 1,819 Mrd. | — | PA Ping An | 0,6 | Sundhedsvæsen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
EF | Aktier | 1,618 Mrd. | — | EF E Fund | 0,2 | Sundhedsvæsen | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,11 | 2,5 | 20,25 |
HE | Aktier | 1,614 Mrd. | — | HE Harvest ETFs | 1,06 | Sundhedsvæsen | | 19.11.2014 | 7,11 | 5,01 | 23,83 |
AM | Aktier | 1,49 Mrd. | — | AM Amundi | 0,5 | Sundhedsvæsen | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9.937,75 | 2,82 | 14,76 |
EF | Aktier | 1,448 Mrd. | — | EF E Fund | 0,2 | Sundhedsvæsen | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,4 | 4,4 | 29,55 |
EF | Aktier | 1,435 Mrd. | — | EF E Fund | 0,2 | Sundhedsvæsen | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,5 | 2,8 | 29,2 |
IS | Aktier | 1,417 Mrd. | — | IS iShares | 0,18 | Sundhedsvæsen | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,11 | 3,73 | 19,22 |
CA | Aktier | 1,391 Mrd. | — | CA Cathay | 1,05 | Sundhedsvæsen | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,22 | 3,39 | 17,66 |
IS | Aktier | 1,361 Mrd. | — | IS iShares | 0,46 | Sundhedsvæsen | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 135,07 | 0 | 0 |
EF | Aktier | 1,323 Mrd. | — | EF E Fund | 0,2 | Sundhedsvæsen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,68 | 3,14 | 28,62 |
GU | Aktier | 1,314 Mrd. | — | GU Guotai | 0,6 | Sundhedsvæsen | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,95 | 0 | 0 |
HA | Aktier | 1,129 Mrd. | — | HA Harvest | 0,6 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,91 | 0 | 0 |
XT | Aktier | 1,116 Mrd. | — | XT Xtrackers | 0,12 | Sundhedsvæsen | MSCI USA / Health Care -SEC | 12.9.2017 | 58,78 | 5,07 | 22,81 |
XT | Aktier | 1,116 Mrd. | — | XT Xtrackers | 0,12 | Sundhedsvæsen | MSCI USA / Health Care -SEC | 12.9.2017 | 58,78 | 5,07 | 22,81 |
VA | Aktier | 1,05 Mrd. | 433.579,7 | VA VanEck | 0,36 | Sundhedsvæsen | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 104,17 | 4,92 | 18,95 |
IS | Aktier | 1,008 Mrd. | 86.576,5 | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Pharmaceutical | 1.5.2006 | 86,97 | 4,59 | 21,41 |
IS | Aktier | 1,001 Mrd. | — | IS iShares | 0,4 | Sundhedsvæsen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,73 | 3,82 | 20,92 |
IS | Aktier | 1,001 Mrd. | — | IS iShares | 0,4 | Sundhedsvæsen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,73 | 3,82 | 20,92 |
GX | Aktier | 977,457 Mio. | — | GX Global X | 0,59 | Sundhedsvæsen | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1.739,46 | 1,9 | 19,17 |
CS | Aktier | 926,443 Mio. | — | CS CSOP | 1,5 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,75 | 3,33 | 23,96 |
| Aktier | 897,705 Mio. | — | WA Wanjia | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,62 | 3,45 | 24,62 |
IS | Aktier | 882,603 Mio. | — | IS iShares | 0,35 | Sundhedsvæsen | NASDAQ / Biotechnology | 19.10.2017 | 8,52 | 0 | 0 |
FT | Aktier | 851,151 Mio. | 27.073,22 | FT First Trust | 0,61 | Sundhedsvæsen | StrataQuant Health Care Index | 8.5.2007 | 110,48 | 3,02 | 17,23 |
AM | Aktier | 827,261 Mio. | — | AM Amundi | 0,3 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 150,86 | 2,85 | 19,76 |
AM | Aktier | 827,261 Mio. | — | AM Amundi | 0,3 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 150,86 | 2,85 | 19,76 |
| Aktier | 742,094 Mio. | 103.248,7 | PB Portfolio Building Block | 0,13 | Sundhedsvæsen | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 25,55 | 4,93 | 20,32 |
CA | Aktier | 721,535 Mio. | — | CA Cathay | 0,41 | Sundhedsvæsen | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 30,05 | 0 | 0 |
IS | Aktier | 706,186 Mio. | — | IS iShares | 0,46 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 113,57 | 3,63 | 19,15 |
IN | Aktier | 703,768 Mio. | 66.288,5 | IN Invesco | 0,4 | Sundhedsvæsen | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 30,28 | 3,04 | 19,91 |
AM | Aktier | 699,02 Mio. | — | AM Amundi | 0,3 | Sundhedsvæsen | MSCI World Index / Health Care -SEC | 19.8.2010 | 469,06 | 7,68 | 29,88 |
IS | Aktier | 670,635 Mio. | 260.406,8 | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Health Care Providers | 1.5.2006 | 42,48 | 2,3 | 16,34 |
GX | Aktier | 626,554 Mio. | — | GX Global X | 0,68 | Sundhedsvæsen | Solactive China Biotech Index | 25.7.2019 | 72,23 | 4,18 | 30,21 |
GX | Aktier | 626,554 Mio. | — | GX Global X | 0,68 | Sundhedsvæsen | Solactive China Biotech Index | 25.7.2019 | 72,23 | 4,18 | 30,21 |
CS | Aktier | 615,176 Mio. | — | CS China Southern | 0,65 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,1 | 2,98 | 21,35 |
SP | Aktier | 604,293 Mio. | — | SP SPDR | 0,3 | Sundhedsvæsen | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 63,22 | 4,44 | 21,81 |
IS | Aktier | 598,291 Mio. | — | IS iShares | 0,18 | Sundhedsvæsen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,46 | 4,16 | 22,04 |
SP | Aktier | 573,552 Mio. | — | SP SPDR | 0,18 | Sundhedsvæsen | MSCI Europe Health Care Index - EUR | 5.12.2014 | 218,89 | 3,73 | 19,22 |
SP | Aktier | 537,261 Mio. | — | SP SPDR | 0,15 | Sundhedsvæsen | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 45,19 | 4,86 | 22,63 |
FU | Aktier | 532,215 Mio. | — | FU Fullgoal | 0,6 | Sundhedsvæsen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,94 | 0 | 0 |
GU | Aktier | 508,014 Mio. | — | GU Guotai | 0,6 | Sundhedsvæsen | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,75 | 3,53 | 27,58 |
DI | Aktier | 504,181 Mio. | 615.495,5 | DI Direxion | 0,96 | Sundhedsvæsen | S&P Biotechnology Select Industry | 28.5.2015 | 171,39 | 0 | 0 |
IS | Aktier | 494,936 Mio. | — | IS iShares | 0,66 | Sundhedsvæsen | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 66,05 | 0 | 0 |
CH | Aktier | 489,926 Mio. | — | CH ChinaAMC | 0,6 | Sundhedsvæsen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,83 | 2,64 | 31,04 |
CS | Aktier | 416,909 Mio. | — | CS China Southern | 0,2 | Sundhedsvæsen | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,65 | 3,14 | 28,61 |
IN | Aktier | 413,365 Mio. | — | IN Invesco | 0,4 | Sundhedsvæsen | NASDAQ / Biotechnology | 6.11.2014 | 59,52 | 4,94 | 21,49 |